BRIEF-Nine out of 10 lost weight with Novo's obesity drug -study

Nov 4 (Reuters) - Novo Nordisk A/S says: * New phase 3a data demonstrate that nine out of 10 adults withobesity lost



weight with liraglutide 3 mg * Clinical trial completers lost an average of 9.2 percent

via Smart Health Shop Forum http://ift.tt/1x3d3S3